SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Leef Brands Inc. (LEEEF) (CIK 0001711141) — Jul 15, 2026

Leef Brands Inc. (LEEEF) (CIK 0001711141)
Date: July 15, 2026 · CIK: 0001711141 · Accession: 0000000000-26-007018

AI Filing Summary & Sentiment

File numbers found in text: 333-297329

Date
July 15, 2026
Author
Not clearly detected
Form
UPLOAD
Company
Leef Brands Inc. (LEEEF) (CIK 0001711141)

Letter

July 15, 2026 Kevin Wilson Chief Financial Officer Leef Brands, Inc. Suite 2500 Park Place 666 Burrard Street Vancouver, BC V6C 2X8, Canada Re: Leef Brands, Inc. Registration Statement on Form S-1 Filed July 9, 2026 File No. 333-297329 Dear Kevin Wilson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jason R. Wisniewski, Esq.

Show Raw Text
July 15, 2026
Kevin Wilson
Chief Financial Officer
Leef Brands, Inc.
Suite 2500 Park Place
666 Burrard Street
Vancouver, BC V6C 2X8, Canada
Re: Leef Brands, Inc.
Registration Statement on Form S-1
Filed July 9, 2026
File No. 333-297329
Dear Kevin Wilson:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jason R. Wisniewski, Esq.